Conversely, tumor-driven remodeling is reactive and localized, characterized by excessive MMP activity, abnormal ECM deposition by cancer-associated fibroblasts (CAFs), and persistent integrin/FAK mechanotransduction that promotes invasion. Here, PTK2 is linked to cancer.